DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

Referenz

Gallamini A, Zaja F, Patti C. , et al.
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

Blood 2007;
110 (07) 2316-2323

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in:
Aufrufen in: